Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Yael L. Maxwell

February 15, 2022

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2018

Shelley Wood

July 02, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Daily News

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Shelley Wood

August 10, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Top Stories in Cardiology, February 2017

Podcast Heart Sounds

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2023

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

TCTMD’s Top 10 Most Popular Stories for June 2019

TCTMD’s Top 10 Most Popular Stories for February 2019

The Biggest News of 2018: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for August 2018

TCTMD’s Top 10 Most Popular Stories for June 2018

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

TCTMD’s Top 10 Most Popular Stories for October 2017

TCTMD’s Top 10 Most Popular Stories for September 2017

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Top Stories in Cardiology, February 2017

TCTMD’s Top 10 Most Popular Stories for November 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content